These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33406698)

  • 1. Seroprevalence of Antibodies against Diphtheria, Tetanus and Pertussis in Adult At-Risk Patients.
    Boey L; Bosmans E; Ferreira LB; Heyvaert N; Nelen M; Smans L; Tuerlinckx H; Roelants M; Claes K; Derdelinckx I; Janssens W; Mathieu C; Van Cleemput J; Vos R; Desombere I; Vandermeulen C
    Vaccines (Basel); 2021 Jan; 9(1):. PubMed ID: 33406698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of antibodies to diphtheria, tetanus and pertussis among healthy adolescents and adults in Iran.
    Pourakbari B; Moradi B; Mirzaee F; Mahmoudi S; Teymuri M; Mamishi S
    Roum Arch Microbiol Immunol; 2013; 72(4):250-4. PubMed ID: 24923108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of Bordetella pertussis antibodies and anti-pertussis antibody response after a single dose of reduced-antigen combined diphtheria, tetanus, and acellular pertussis vaccine (Tdap) in pregnant Thai women.
    Sompagdee N; Anuwutnavin S; Phongsamart W; Senawong S; Umrod P; Robkhonburi A
    Vaccine; 2020 Mar; 38(12):2725-2733. PubMed ID: 32070680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fifth vaccination with dipthteria, tetanus and acellular pertussis is beneficial in four- to six-year-olds.
    Pichichero ME; Anderson EL; Rennels MB; Edwards KM; England JA
    Pediatr Infect Dis J; 2001 Apr; 20(4):427-33. PubMed ID: 11332669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of antibodies against diphtheria, tetanus, and pertussis among healthy Thai adolescents.
    Hanvatananukul P; Prasarakee C; Sarachai S; Aurpibul L; Sintupat K; Khampan R; Saheng J; Sudjaritruk T
    Int J Infect Dis; 2020 Jul; 96():422-430. PubMed ID: 32387447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19-64 years of age.
    Blatter M; Friedland LR; Weston WM; Li P; Howe B
    Vaccine; 2009 Jan; 27(5):765-72. PubMed ID: 19041352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum antibodies to diphtheria-tetanus-pertussis vaccine components in Argentine children.
    Pasetti M; Eriksson P; Ferrero F; Manghi M
    Infection; 1997; 25(6):339-45. PubMed ID: 9427051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary immunization with a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian infants: an analysis of antibody response.
    Zarei S; Jeddi-Tehrani M; Akhondi MM; Zeraati H; Pourheidari F; Ostadkarampour M; Tavangar B; Shokri F
    Iran J Allergy Asthma Immunol; 2009 Jun; 8(2):85-93. PubMed ID: 19671937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults.
    Brandon D; Kimmel M; Kuriyakose SO; Kostanyan L; Mesaros N
    Vaccine; 2018 Oct; 36(42):6325-6333. PubMed ID: 30197282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of an antibody against diphtheria, tetanus, and pertussis among the elderly in Khon Kaen, Thailand.
    Chinchai T; Posuwan N; Vuthitanachot V; Wanlapakorn N; Poovorawan Y
    J Health Popul Nutr; 2019 Oct; 38(1):28. PubMed ID: 31627764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Belgian Serosurveillance/Seroprevalence Study of Diphtheria, Tetanus and Pertussis Using a Luminex xMAP Technology-Based Pentaplex.
    Caboré RN; Piérard D; Huygen K
    Vaccines (Basel); 2016 May; 4(2):. PubMed ID: 27171114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low seroprevalence of diphtheria, tetanus and pertussis in ambulatory adult patients: the need for lifelong vaccination.
    Tanriover MD; Soyler C; Ascioglu S; Cankurtaran M; Unal S
    Eur J Intern Med; 2014 Jul; 25(6):528-32. PubMed ID: 24814432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis®) in adults aged ≥ 40 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years.
    Dominicus R; Galtier F; Richard P; Baudin M
    Vaccine; 2014 Jun; 32(31):3942-9. PubMed ID: 24852717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of maternal vaccination against diphtheria, tetanus, and pertussis on the avidity of infant antibody responses to a pertussis containing vaccine in Belgium.
    Caboré RN; Maertens K; Dobly A; Leuridan E; Van Damme P; Huygen K
    Virulence; 2017 Oct; 8(7):1245-1254. PubMed ID: 28277900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of antibodies to pertussis and diphtheria among healthy adults in China.
    Zhang Q; Han F; Nie Q; Ren H; Zhang B; Liu Q; He Q; Shao Z
    J Infect; 2011 Dec; 63(6):441-6. PubMed ID: 21864569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody response to diphtheria-tetanus-pertussis immunization in preterm infants who receive dexamethasone for chronic lung disease.
    Robinson MJ; Heal C; Gardener E; Powell P; Sims DG
    Pediatrics; 2004 Apr; 113(4):733-7. PubMed ID: 15060220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetanus and Diphtheria Seroprotection among Children Younger Than 15 Years in Nigeria, 2018: Who Are the Unprotected Children?
    Tohme RA; Scobie HM; Okunromade O; Olaleye T; Shuaib F; Jegede T; Yahaya R; Nnaemeka N; Lawal B; Egwuenu A; Parameswaran N; Cooley G; An Q; Coughlin M; Okposen BB; Adetifa I; Bolu O; Ihekweazu C
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decennial administration in young adults of a reduced-antigen content diphtheria, tetanus, acellular pertussis vaccine containing two different concentrations of aluminium.
    Vandermeulen C; Theeten H; Rathi N; Kuriyakose S; Han HH; Sokal E; Hoppenbrouwers K; Van Damme P
    Vaccine; 2015 Jun; 33(26):3026-34. PubMed ID: 25613716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diphtheria, tetanus and pertussis antibodies in 10-year-old children before and after a booster dose of three toxoids: implications for the timing of a booster dose.
    Trollfors B; Knutsson N; Taranger J; Mark A; Bergfors E; Sundh V; Lagergård T
    Eur J Pediatr; 2006 Jan; 165(1):14-8. PubMed ID: 16249929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diphtheria, tetanus, poliomyelitis, yellow fever and hepatitis B seroprevalence among HIV1-infected migrants. Results from the ANRS VIHVO vaccine sub-study.
    Mullaert J; Abgrall S; Lele N; Batteux F; Slama LB; Meritet JF; Lebon P; Bouchaud O; Grabar S; Launay O;
    Vaccine; 2015 Sep; 33(38):4938-44. PubMed ID: 26209841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.